2023 Government Hospital Patient-Centered 
Physician's Weekly
JUNE 24, 2025
has long disparaged certain vaccines, calling them unsafe and saying that the government officials who regulate them are compromised and corrupt. On June 9, Kennedy fired a panel of scientific advisers to the Centers for Disease Control and Prevention, and later replaced them with some who have been skeptical of vaccines. Kennedy Jr.,
PEMBlog
JUNE 7, 2023
After listening to this episode you will be able to: Identify unique aspects of the pre-hospital environment that impact assessment and treatment of agitated children Describe the role of EMS personnel and EMS director in the care of agitated children.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PEMBlog
MAY 31, 2023
When we think of managing agitated patients we think of medicines – but that shouldn’t be our first option. However, medications can be adjuncts to non-pharmacologic means to help keep agitated children safe from harm.
PEMBlog
MAY 17, 2023
Furthermore, the connection between physical and functional symptoms is inextricably linked in many patients. Government. Diagnostic yield of head CT in pediatric emergency department patients with acute psychosis or hallucinations. Why then do we persist with the “is it medical/organic or psych” question?
FDA Law Blog
JULY 17, 2022
An example of such a drug is a single-use vial of an injectable cancer drug that is dosed based upon weight, and therefore might not be entirely used for a lighter weight patient. On July 8, as part of its annual physician fee schedule update for 2023, CMS issued a proposed regulation to implement the new refund.
FDA Law Blog
MAY 30, 2024
The 340B statute requires drug manufacturers to sell certain drugs at discounted ceiling prices to covered entities, which are defined by statute to include certain types of safety net hospitals, health centers, and clinics receiving federal grants. District Court and won, prompting a government appeal to the D.C.
FDA Law Blog
JANUARY 5, 2023
To date, regulatory enforcement litigation focused on actual or imminent patient harm has taken a backseat to cybersecurity as FDA continues to update and implement its oversight framework. More updates will follow here as trends develop in 2023.
Expert insights. Personalized for you.
52 
Let's personalize your content